Tricol Biomedical, Inc. is a medical device company on a mission to achieve zero preventable deaths due to blood loss. Their slogan, "The blood stops here," encapsulates their commitment to innovation in hemostasis.
Founded in 2001, Tricol is dedicated to significantly advancing the standard of care in hemostatic and wound care management. The company's HemCon product line, which originated on the battlefield, has expanded to address market needs in Trauma Management, Procedural Care, and Consumer Self-Care. Tricol Biomedical operates at the forefront of bleeding control and wound care technology, emphasizing quality and innovation. Currently headquartered in the United States, the company's latest investment details, including investors and date, are currently unavailable.
There is no investment information
No recent news or press coverage available for Tricol Biomedical, Inc..